Abstract
Introduction
Paracetamol pharmacokinetics (PK) is highly variable in older fit adults after intravenous administration. Frailty and oral administration likely result in additional variability. The aim was to determine oral paracetamol PK and variability in geriatric inpatients.
Methods
A population PK analysis, using NONMEM 7.2, was performed on 245 paracetamol samples in 40 geriatric inpatients (median age 87 [range 80–95] years, bodyweight 66.4 [49.3–110] kg, 92.5% frail [Edmonton Frail Scale]). All subjects received paracetamol 1000 mg as tablet (72.5%) or granulate (27.5%) three times daily. Simulations of dosing regimens (1000 mg every 6 hours [q6h] or q8h) were performed to determine target attainment, using mean steady-state concentration (Css-mean) of 10 mg/L as target.
Results
A one-compartment model with first order absorption and lag time best described the data. The inter-individual variability was high, with absorption rate constant containing the highest variability. The inter-individual variability could not be explained by covariates. Simulations of 1000 mg q6h and q8h resulted in a Css-mean of 10.8 [25–75th percentiles 8.2–12.7] and 8.13 [6.3–9.6] mg/L, respectively, for the average geriatric inpatient. The majority of the population remained off-target (22.2% [q6h] and 52.2% [q8h] <8 mg/L; 31.3 [q6h] and 7.6% [q8h] >12 mg/L).
Conclusion
A population of average geriatric inpatients achieved target Css-mean with paracetamol 1000 mg q6h, while q8h resulted in underexposure for the majority of them. Due to high unexplained variability, a relevant proportion remained either above or below the target concentration of 10 mg/L. Research focusing on PK, efficacy and safety is needed to recommend dosing regimens.
Similar content being viewed by others
References
Gibson SJ, Lussier D. Prevalence and relevance of pain in older persons. Pain Med. 2012;13(Suppl 2):S23–6. https://doi.org/10.1111/j.1526-4637.2012.01349.x.
Molton IR, Terrill AL. Overview of persistent pain in older adults. Am Psychol. 2014;69(2):197–207. https://doi.org/10.1037/a0035794.
Marcum ZA, Duncan NA, Makris UE. Pharmacotherapies in geriatric chronic pain management. Clin Geriatr Med. 2016;32(4):705–24. https://doi.org/10.1016/j.cger.2016.06.007.
Safe acetaminophen use guideline. Goverment Q. 2014. https://www.health.qld.gov.au/__data/assets/pdf_file/0030/147666/qh-gdl-415.pdf. Accessed 15 Jun 2018.
What dose of paracetamol for older people? Drug Ther Bull. 2018;56(6):69–72. https://doi.org/10.1136/dtb.2018.6.0636.
Boparai MK, Korc-Grodzicki B. Prescribing for older adults. Mt Sinai J Med. 2011;78(4):613–26. https://doi.org/10.1002/msj.20278.
ElDesoky ES. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther. 2007;14(5):488–98. https://doi.org/10.1097/01.mjt.0000183719.84390.4d.
Allegaert K, Olkkola KT, Owens KH, Van de Velde M, de Maat MM, Anderson BJ, et al. Covariates of intravenous paracetamol pharmacokinetics in adults. BMC Anesthesiol. 2014;14:77. https://doi.org/10.1186/1471-2253-14-77.
Bannwarth B, Pehourcq F, Lagrange F, Matoga M, Maury S, Palisson M, et al. Single and multiple dose pharmacokinetics of acetaminophen (paracetamol) in polymedicated very old patients with rheumatic pain. J Rheumatol. 2001;28(1):182–4.
Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Niemi M, Neuvonen PJ, et al. Pharmacokinetics of intravenous paracetamol in elderly patients. Clin Pharmacokinet. 2011;50(2):121–9. https://doi.org/10.2165/11537240-000000000-00000.
Johnston C, Hilmer SN, McLachlan AJ, Matthews ST, Carroll PR, Kirkpatrick CM. The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration. Eur J Clin Pharmacol. 2014;70(5):549–55. https://doi.org/10.1007/s00228-014-1652-7.
Rockwood K, Howlett SE. Fifteen years of progress in understanding frailty and health in aging. BMC Med. 2018;16(1):220. https://doi.org/10.1186/s12916-018-1223-3.
Ellmers SEPL, Notarianni LJ, Jones RW. Excretion of paracetamol in fit and frail elderly people. J Am Geriatr Soc. 1991;31(596):597.
Wynne HA, Cope LH, Herd B, Rawlins MD, James OF, Woodhouse KW. The association of age and frailty with paracetamol conjugation in man. Age Ageing. 1990;19(6):419–24.
Mian P, van Esdonk MJ, Olkkola KT, de Winter BCM, Liukas A, Spriet I, et al. Population pharmacokinetic modelling of intravenous paracetamol in fit older people displays extensive unexplained variability. Br J Clin Pharmacol. 2019;85(1):126–35. https://doi.org/10.1111/bcp.13770.
Corsi N, Roberto A, Cortesi L, Nobili A, Mannucci PM, Corli O, et al. Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards. Eur J Intern Med. 2018;55:35–9. https://doi.org/10.1016/j.ejim.2018.05.031.
Gibb IA, Anderson BJ. Paracetamol (acetaminophen) pharmacodynamics: interpreting the plasma concentration. Arch Dis Child. 2008;93(3):241–7. https://doi.org/10.1136/adc.2007.126896.
Hias J, Van der Linden L, Walgraeve K, Gijsen M, Mian P, Koch BCP, Allegaert K, Annaert P, Tournoy J, Spriet I. Pharmacokinetics of 2 oral paracetamol formulations in hospitalized octogenarians. Br J Clin Pharmacol. 2021. https://doi.org/10.1111/bcp.15049
Flint RB, Mian P, van der Nagel B, Slijkhuis N, Koch BC. Quantification of acetaminophen and its metabolites in plasma using UPLC-MS: doors open to therapeutic drug monitoring in special patient populations. Ther Drug Monit. 2017;39(2):164–71. https://doi.org/10.1097/FTD.0000000000000379.
Nguyen TH, Mouksassi MS, Holford N, Al-Huniti N, Freedman I, Hooker AC, et al. Model evaluation of continuous data pharmacometric models: metrics and graphics. CPT Pharmacometrics Syst Pharmacol. 2017;6(2):87–109. https://doi.org/10.1002/psp4.12161.
Savic RM, Jonker DM, Kerbusch T, Karlsson MO. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. J Pharmacokinet Pharmacodyn. 2007;34(5):711–26. https://doi.org/10.1007/s10928-007-9066-0.
Petersson KJ, Hanze E, Savic RM, Karlsson MO. Semiparametric distributions with estimated shape parameters. Pharm Res. 2009;26(9):2174–85. https://doi.org/10.1007/s11095-009-9931-1.
Rodriguez-Manas L, Feart C, Mann G, Vina J, Chatterji S, Chodzko-Zajko W, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci. 2013;68(1):62–7. https://doi.org/10.1093/gerona/gls119.
Cerreta F, Eichler HG, Rasi G. Drug policy for an aging population–the European Medicines Agency’s geriatric medicines strategy. N Engl J Med. 2012;367(21):1972–4. https://doi.org/10.1056/NEJMp1209034.
Booker SS, Bartoszczyk DA, Herr KA. Managing pain in frail elders. Am Nurse Today. 2016;11(4). https://www.americannursetoday.com/managing-pain-frail-elders/
Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol. 2002;40(1):3–20.
Miners JO, Penhall R, Robson RA, Birkett DJ. Comparison of paracetamol metabolism in young adult and elderly males. Eur J Clin Pharmacol. 1988;35(2):157–60.
Bos JC, Misticio MC, Nunguiane G, Mathot RAA, van Hest RM, Prins JM. Paracetamol clinical dosing routine leads to paracetamol underexposure in an adult severely ill sub-Saharan African hospital population: a drug concentration measurement study. BMC Res Notes. 2017;10(1):671. https://doi.org/10.1186/s13104-017-3016-8.
Sabate M, Ibanez L, Perez E, Vidal X, Buti M, Xiol X, et al. Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series. BMC Gastroenterol. 2011;11:80. https://doi.org/10.1186/1471-230X-11-80.
Ging P, Mikulich O, O’Reilly KM. Unexpected paracetamol (acetaminophen) hepatotoxicity at standard dosage in two older patients: time to rethink 1 g four times daily? Age Ageing. 2016;45(4):566–7. https://doi.org/10.1093/ageing/afw067.
Mitchell SJ, Kane AE, Hilmer SN. Age-related changes in the hepatic pharmacology and toxicology of paracetamol. Curr Gerontol Geriatr Res. 2011;2011: 624156. https://doi.org/10.1155/2011/624156.
Valente MA, Hillege HL, Navis G, Voors AA, Dunselman PH, van Veldhuisen DJ, et al. The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure. Eur J Heart Fail. 2014;16(1):86–94. https://doi.org/10.1093/eurjhf/hft128.
Acknowledgements
We greatly acknowledge K. Hagoort for editorial assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
All authors declare that no funding for this project has been received.
Conflict of interest
All authors declare no conflicts of interest.
Ethics approval
This study was conducted at the University Hospitals Leuven, Belgium, following approval by the medical ethics committee of UZ Leuven (EUDRACT 2015-004217-24).
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Data availability
The data that support the findings of this study are available on request from the corresponding author.
Code availability
Available upon request to the corresponding author.
Author contributions
LvdH and PM wrote the manuscript; LvdH, PM, LvdL, JH, BK, BdW, DT, JT, JF, KW, and IS edited the manuscript; LvdH and PM provided graphics for the manuscript; LvdH, PM, KA, BK and BdW performed research for the manuscript; LvdH, PM, KA, IS, BK and BdW designed the research; and IS, KA, BK and BdW supervised the research. All authors read and approved the final version of the paper.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
van der Heijden, L.T., Mian, P., Hias, J. et al. Highly Variable Paracetamol Pharmacokinetics After Multiple Oral Dosing in Frail Older People: A Population Pharmacokinetic Analysis. Drugs Aging 39, 83–95 (2022). https://doi.org/10.1007/s40266-021-00912-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40266-021-00912-z